Proton magnetic resonance spectroscopy and MRI reveal no evidence for brain mitochondrial dysfunction in children with autism spectrum disorder
- PMID: 21404085
- DOI: 10.1007/s10803-011-1216-y
Proton magnetic resonance spectroscopy and MRI reveal no evidence for brain mitochondrial dysfunction in children with autism spectrum disorder
Abstract
Brain mitochondrial dysfunction has been proposed as an etiologic factor in autism spectrum disorder (ASD). Proton magnetic resonance spectroscopic imaging ((1)HMRS) and MRI were used to assess for evidence of brain mitochondrial dysfunction in longitudinal samples of children with ASD or developmental delay (DD), and cross-sectionally in typically developing (TD) children at 3-4, 6-7 and 9-10 years-of-age. A total of 239 studies from 130 unique participants (54ASD, 22DD, 54TD) were acquired. (1)HMRS and MRI revealed no evidence for brain mitochondrial dysfunction in the children with ASD. Findings do not support a substantive role for brain mitochondrial abnormalities in the etiology or symptom expression of ASD, nor the widespread use of hyperbaric oxygen treatment that has been advocated on the basis of this proposed relationship.
Comment in
-
Substantial problems with measuring brain mitochondrial dysfunction in autism spectrum disorder using magnetic resonance spectroscopy.J Autism Dev Disord. 2012 Apr;42(4):640-2; author reply 643-6. doi: 10.1007/s10803-011-1276-z. J Autism Dev Disord. 2012. PMID: 21556966 No abstract available.
Similar articles
-
Mitochondrial dysfunction as a neurobiological subtype of autism spectrum disorder: evidence from brain imaging.JAMA Psychiatry. 2014 Jun;71(6):665-71. doi: 10.1001/jamapsychiatry.2014.179. JAMA Psychiatry. 2014. PMID: 24718932 Free PMC article.
-
Atypical developmental patterns of brain chemistry in children with autism spectrum disorder.JAMA Psychiatry. 2013 Sep;70(9):964-74. doi: 10.1001/jamapsychiatry.2013.1388. JAMA Psychiatry. 2013. PMID: 23903694
-
Gray and white matter brain chemistry in young children with autism.Arch Gen Psychiatry. 2006 Jul;63(7):786-94. doi: 10.1001/archpsyc.63.7.786. Arch Gen Psychiatry. 2006. PMID: 16818868
-
Proton magnetic resonance spectroscopy as a probe into the pathophysiology of autism spectrum disorders (ASD): a review.Autism Res. 2013 Apr;6(2):119-33. doi: 10.1002/aur.1273. Epub 2013 Feb 21. Autism Res. 2013. PMID: 23436782 Review.
-
Candidate Biomarkers in Children with Autism Spectrum Disorder: A Review of MRI Studies.Neurosci Bull. 2017 Apr;33(2):219-237. doi: 10.1007/s12264-017-0118-1. Epub 2017 Mar 10. Neurosci Bull. 2017. PMID: 28283808 Free PMC article. Review.
Cited by
-
Mitochondrial dysfunction as a neurobiological subtype of autism spectrum disorder: evidence from brain imaging.JAMA Psychiatry. 2014 Jun;71(6):665-71. doi: 10.1001/jamapsychiatry.2014.179. JAMA Psychiatry. 2014. PMID: 24718932 Free PMC article.
-
Torasemide Improves the Propionic Acid-Induced Autism in Rats: A Histopathological and Imaging Study.Alpha Psychiatry. 2023 Jan 1;24(1):22-31. doi: 10.5152/alphapsychiatry.2023.22975. eCollection 2023 Jan. Alpha Psychiatry. 2023. PMID: 36879996 Free PMC article.
-
Age-related change in brain metabolite abnormalities in autism: a meta-analysis of proton magnetic resonance spectroscopy studies.Transl Psychiatry. 2012 Jan 17;2(1):e69. doi: 10.1038/tp.2011.65. Transl Psychiatry. 2012. PMID: 22832731 Free PMC article.
-
Evidence linking oxidative stress, mitochondrial dysfunction, and inflammation in the brain of individuals with autism.Front Physiol. 2014 Apr 22;5:150. doi: 10.3389/fphys.2014.00150. eCollection 2014. Front Physiol. 2014. PMID: 24795645 Free PMC article. Review.
-
Atorvastatin Improves the Propionic Acid-Induced Autism in Rats: The Roles of Sphingosine-1-Phosphate and Anti-inflammatory Action.Cureus. 2023 Mar 29;15(3):e36870. doi: 10.7759/cureus.36870. eCollection 2023 Mar. Cureus. 2023. PMID: 37123681 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources